Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
Marriott put volume heavy and directionally bearish » 12:15
09/20/21
09/20
12:15
09/20/21
12:15
MAR

Marriott

$140.84 /

-3.12 (-2.17%)

Bearish flow noted in…

Bearish flow noted in Marriott with 1,876 puts trading, or 1.1x expected. Most active are Oct-21 105 puts and Oct-21 115 puts, with total volume in those strikes near 800 contracts. The Put/Call Ratio is 1.61, while ATM IV is up nearly 5 points on the day. Earnings are expected on November 5th.

ShowHide Related Items >><<
MAR Marriott
$140.84 /

-3.12 (-2.17%)

MAR Marriott
$140.84 /

-3.12 (-2.17%)

08/04/21 BMO Capital
Marriott price target raised to $145 from $140 at BMO Capital
05/12/21 Truist
Marriott price target raised to $133 from $119 at Truist
05/10/21 Stifel
Marriott price target raised to $140 from $120 at Stifel
02/24/21 Stifel
American Airlines price target raised to $20 from $14 at Stifel
MAR Marriott
$140.84 /

-3.12 (-2.17%)

MAR Marriott
$140.84 /

-3.12 (-2.17%)

MAR Marriott
$140.84 /

-3.12 (-2.17%)

MAR Marriott
$140.84 /

-3.12 (-2.17%)

Hot Stocks
Marriott, Progetto Majestic enter agreement to debut W Hotel in Tuscany » 11:04
09/20/21
09/20
11:04
09/20/21
11:04
MAR

Marriott

$141.08 /

-2.88 (-2.00%)

Marriott International…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MAR Marriott
$141.08 /

-2.88 (-2.00%)

MAR Marriott
$141.08 /

-2.88 (-2.00%)

08/04/21 BMO Capital
Marriott price target raised to $145 from $140 at BMO Capital
05/12/21 Truist
Marriott price target raised to $133 from $119 at Truist
05/10/21 Stifel
Marriott price target raised to $140 from $120 at Stifel
02/24/21 Stifel
American Airlines price target raised to $20 from $14 at Stifel
MAR Marriott
$141.08 /

-2.88 (-2.00%)

MAR Marriott
$141.08 /

-2.88 (-2.00%)

MAR Marriott
$141.08 /

-2.88 (-2.00%)

MAR Marriott
$141.08 /

-2.88 (-2.00%)

Hot Stocks
DuPont joins Water Resilience Coalition, signs CEO Water Mandate » 09:27
09/20/21
09/20
09:27
09/20/21
09:27
DD

DuPont

$68.92 /

-1.71 (-2.42%)

DuPont announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DD DuPont
$68.92 /

-1.71 (-2.42%)

DD DuPont
$68.92 /

-1.71 (-2.42%)

08/04/21 Citi
DuPont price target raised to $102 from $96 at Citi
07/06/21 Credit Suisse
DuPont assumed with a Neutral at Credit Suisse
05/26/21 Morgan Stanley
DuPont resumed with an Equal Weight at Morgan Stanley
05/14/21 Argus
DuPont price target raised to $93 from $81 at Argus
DD DuPont
$68.92 /

-1.71 (-2.42%)

DD DuPont
$68.92 /

-1.71 (-2.42%)

DD DuPont
$68.92 /

-1.71 (-2.42%)

DD DuPont
$68.92 /

-1.71 (-2.42%)

Hot Stocks
L3Harris gets approval from SDA for missile tracking satellites plan » 09:16
09/20/21
09/20
09:16
09/20/21
09:16
LHX

L3Harris Technologies

$222.59 /

+1.545 (+0.70%)

L3Harris Technologies …

L3Harris Technologies has accomplished a key milestone in the development of a missile tracking satellite prototype for the Space Development Agency, SDA. The completed Preliminary Design Review defines the spacecraft's design baseline for delivery to SDA and allows the program to move to the next stage of delivering ground-breaking new capabilities at speed. When completed, the satellites will provide the capability to detect and track ballistic and hypersonic missiles via overhead persistent infrared sensing from low earth orbit. The completed Preliminary Design Review defines the spacecraft's design baseline for delivery to SDA and allows the program to move to the next stage of delivering ground-breaking new capabilities at speed. When completed, the satellites will provide the capability to detect and track ballistic and hypersonic missiles via overhead persistent infrared sensing from low earth orbit. "We've worked closely with SDA to ensure our design taps proven technology that can scale to address the changing mission," said Ed Zoiss, President of L3Harris Space and Airborne Systems. "We understand the threat and are focused on delivery."

ShowHide Related Items >><<
LHX L3Harris Technologies
$222.59 /

+1.545 (+0.70%)

LHX L3Harris Technologies
$222.59 /

+1.545 (+0.70%)

09/08/21 Wolfe Research
L3Harris Technologies initiated with a Peer Perform at Wolfe Research
08/11/21
Fly Intel: Top five analyst downgrades
08/11/21 Morgan Stanley
L3Harris Technologies downgraded to Equal Weight from Overweight at Morgan Stanley
08/04/21 Credit Suisse
L3Harris Technologies price target raised to $254 from $243 at Credit Suisse
LHX L3Harris Technologies
$222.59 /

+1.545 (+0.70%)

LHX L3Harris Technologies
$222.59 /

+1.545 (+0.70%)

Conference/Events
European Society for Medical Oncology to hold a virtual meeting » 04:55
09/20/21
09/20
04:55
09/20/21
04:55
ABBV

AbbVie

$107.75 /

-0.33 (-0.31%)

, AYLA

Ayala Pharmaceuticals

$12.25 /

-0.01 (-0.08%)

, DCPH

Deciphera

$33.08 /

+1.45 (+4.58%)

, GMAB

Genmab

$43.10 /

+0.845 (+2.00%)

, LPTX

Leap Therapeutics

$2.65 /

+0.13 (+5.16%)

, ORIC

Oric Pharmaceuticals

$25.20 /

+0.99 (+4.09%)

, SYNH

Syneos Health

$94.34 /

+0.55 (+0.59%)

, BGNE

BeiGene

$403.60 /

+18.32 (+4.75%)

, BMY

Bristol-Myers

$61.32 /

+0.1 (+0.16%)

, BYSI

BeyondSpring

$23.00 /

+0.47 (+2.09%)

, CALA

Calithera Biosciences

$2.25 /

+0.2 (+9.76%)

, GILD

Gilead

$71.61 /

+0.34 (+0.48%)

, GH

Guardant Health

$132.01 /

+5.01 (+3.94%)

, LLY

Eli Lilly

$230.17 /

-0.78 (-0.34%)

, IPSEY

Ipsen

$23.92 /

-0.395 (-1.62%)

, EXAS

Exact Sciences

$108.29 /

+5.47 (+5.32%)

, IDYA

Ideaya Biosciences

$26.90 /

+0.9 (+3.46%)

, GSK

GlaxoSmithKline

$38.94 /

-0.16 (-0.41%)

, RHHBY

Roche

$46.07 /

-0.75 (-1.60%)

, REGN

Regeneron

$651.38 /

-2.3 (-0.35%)

, PFE

Pfizer

$43.89 /

-0.57 (-1.28%)

, TAK

Takeda Pharmaceutical

$17.16 /

-0.045 (-0.26%)

, TMO

Thermo Fisher

$596.98 /

+36.11 (+6.44%)

, TCRR

TCR2 Therapeutics

$10.00 /

-5.715 (-36.38%)

, VERU

Veru

$8.94 /

+0.17 (+1.94%)

, VBLT

VBL Therapeutics

$2.32 /

-0.035 (-1.49%)

, VTRS

Viatris

$13.57 /

-0.13 (-0.95%)

, NVS

Novartis

$83.49 /

-0.88 (-1.04%)

ESMO 2021 Virtual…

ESMO 2021 Virtual Congress will be held on September 16-21. Webcast Link

ShowHide Related Items >><<
VTRS Viatris
$13.57 /

-0.13 (-0.95%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

VBLT VBL Therapeutics
$2.32 /

-0.035 (-1.49%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

IPSEY Ipsen
$23.92 /

-0.395 (-1.62%)

IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GMAB Genmab
$43.10 /

+0.845 (+2.00%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

GH Guardant Health
$132.01 /

+5.01 (+3.94%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

DCPH Deciphera
$33.08 /

+1.45 (+4.58%)

CALA Calithera Biosciences
$2.25 /

+0.2 (+9.76%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

AYLA Ayala Pharmaceuticals
$12.25 /

-0.01 (-0.08%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

09/14/21 Barclays
Regenxbio price target raised to $82 from $79 at Barclays
09/13/21 Chardan
Regenxbio pact with AbbVie accelerates RGX-314 'value capture,' says Chardan
09/08/21 JPMorgan
AbbVie offers 'best risk/reward story in the group,' says JPMorgan
09/07/21 Morgan Stanley
Morgan Stanley cuts Vertex Pharmaceuticals to Underweight amid AbbVie overhang
AYLA Ayala Pharmaceuticals
$12.25 /

-0.01 (-0.08%)

07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with Buy, $29 target at Ladenburg
07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with a Buy at Ladenburg
12/07/20
Fly Intel: Top five analyst initiations
12/07/20 Roth Capital
Ayala Pharmaceuticals initiated with a Buy at Roth Capital
DCPH Deciphera
$33.08 /

+1.45 (+4.58%)

08/04/21 H.C. Wainwright
Deciphera price target lowered to $70 from $75 at H.C. Wainwright
05/05/21 Barclays
Deciphera price target lowered to $65 from $70 at Barclays
05/05/21 H.C. Wainwright
Deciphera price target lowered to $75 from $80 at H.C. Wainwright
05/05/21 Piper Sandler
Deciphera price target lowered to $60 from $75 at Piper Sandler
GMAB Genmab
$43.10 /

+0.845 (+2.00%)

09/16/21
Fly Intel: Top five analyst downgrades
09/16/21 Jefferies
Genmab downgraded to Hold from Buy at Jefferies
09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley cuts Genmab to Underweight amid high investor expectations
LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

09/19/21 Piper Sandler
Piper Sandler keeps Overweight on Leap Therapeutics, ups target to $5
09/16/21 Piper Sandler
Leap data show 'very favorable early signal,' says Piper Sandler
09/13/21 Raymond James
Leap Therapeutics price target raised to $4 from $3 at Raymond James
09/13/21 Piper Sandler
Leap combo sees 'strong' early response rate, says Piper Sandler
ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy after tumor data at Citi
07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy from Neutral at Citi
03/25/21 H.C. Wainwright
Oric Pharmaceuticals price target raised to $54 from $52 at H.C. Wainwright
01/25/21 Citi
Oric Pharmaceuticals downgraded to Neutral from Buy at Citi
SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

08/04/21 Credit Suisse
Syneos Health assumed with an Outperform at Credit Suisse
07/13/21 Barclays
Syneos Health price target raised to $102 from $90 at Barclays
06/02/21 Truist
Syneos Health price target raised to $104 from $88 at Truist
04/30/21 Mizuho
Syneos Health price target raised to $90 from $82 at Mizuho
BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

09/08/21 Baird
BeyondSpring initiated with an Outperform at Baird
08/04/21 Evercore ISI
BeyondSpring price target raised to $95 from $30 at Evercore ISI
08/04/21 William Blair
BeyondSpring may have new standard of care in lung cancer, says William Blair
08/04/21 H.C. Wainwright
Wainwright upgrades BeyondSpring with $100 target on lung cancer data
CALA Calithera Biosciences
$2.25 /

+0.2 (+9.76%)

01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform at SVB Leerink
01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform from Outperform at SVB Leerink
01/05/21 Citi
Calithera Biosciences price target lowered to $5 from $10 at Citi
01/05/21 H.C. Wainwright
Calithera Biosciences price target lowered to $4 from $9.50 at H.C. Wainwright
GILD Gilead
$71.61 /

+0.34 (+0.48%)

07/30/21 BMO Capital
Gilead price target raised to $72 from $67 at BMO Capital
07/30/21 RBC Capital
Gilead price target raised to $84 from $81 at RBC Capital
06/29/21 Jefferies
Gilead data should move Yescarta up to second line in DLBCL, says Jefferies
GH Guardant Health
$132.01 /

+5.01 (+3.94%)

08/09/21 Canaccord
Guardant Health price target lowered to $180 from $195 at Canaccord
06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Guardant Health initiated with a Market Perform at Raymond James
LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

09/02/21 SVB Leerink
AbbVie price target lowered to $142 from $148 at SVB Leerink
08/30/21 Cowen
Eli Lilly price target raised to $300 from $250 at Cowen
08/30/21 Citi
Lexicon price target raised to $20 from $13 at Citi
IPSEY Ipsen
$23.92 /

-0.395 (-1.62%)

08/16/21 Morgan Stanley
Ipsen price target lowered to EUR 88 from EUR 92 at Morgan Stanley
08/03/21 Morgan Stanley
Ipsen price target raised to EUR 92 from EUR 85 at Morgan Stanley
08/02/21 Societe Generale
Ipsen price target raised to EUR 101 from EUR 90 at Societe Generale
07/30/21 Credit Suisse
Ipsen price target raised to EUR 90 from EUR 75 at Credit Suisse
EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
09/15/21 Canaccord
Exact Sciences progress in MRD space a positive, says Canaccord
09/01/21 Baird
UnitedHealth update to CRC screening coverage not a surprise, says Baird
IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

06/03/21 Baird
Ideaya Biosciences assumed with an Outperform at Baird
04/22/21 Roth Capital
Ideaya Biosciences price target raised to $38 from $31 at Roth Capital
04/19/21 H.C. Wainwright
Ideaya Biosciences price target raised to $35 from $29 at H.C. Wainwright
04/16/21 Roth Capital
Ideaya Biosciences price target raised to $31 from $23 at Roth Capital
GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

08/26/21 UBS
GlaxoSmithKline price target raised to 1,540 GBp from 1,485 GBp at UBS
08/20/21 JPMorgan
GlaxoSmithKline price target raised to 1,500 GBp from 1,300 GBp at JPMorgan
08/19/21 Berenberg
GlaxoSmithKline price target raised to 1,625 GBp from 1,570 GBp at Berenberg
RHHBY Roche
$46.07 /

-0.75 (-1.60%)

09/07/21 UBS
Roche price target raised to CHF 350 from CHF 345 at UBS
08/02/21 JPMorgan
Roche price target raised to CHF 360 from CHF 310 at JPMorgan
07/27/21 Societe Generale
Roche price target raised to CHF 353 from CHF 340 at Societe Generale
REGN Regeneron
$651.38 /

-2.3 (-0.35%)

09/15/21 Cantor Fitzgerald
Regeneron price target raised to $700 from $670 at Cantor Fitzgerald
09/15/21 H.C. Wainwright
Regeneron price target raised to $831 from $787 at H.C. Wainwright
09/15/21 Piper Sandler
Regeneron price target raised to $690 from $675 at Piper Sandler
09/09/21
Fly Intel: Top five analyst initiations
PFE Pfizer
$43.89 /

-0.57 (-1.28%)

09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

08/03/21 Piper Sandler
Arcturus strength attributable to large pharma's interest in mRNA, says Piper
04/27/21 Chardan
LogicBio collaborations may signal recognition of platforms, says Chardan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

08/04/21 Credit Suisse
Thermo Fisher assumed with an Outperform at Credit Suisse
08/04/21 Argus
Thermo Fisher price target raised to $600 from $530 at Argus
07/29/21 Cowen
Thermo Fisher price target raised to $560 from $525 at Cowen
07/29/21 BTIG
Thermo Fisher price target raised to $610 from $590 at BTIG
TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

09/17/21 Wedbush
TCR2 Therapeutics downgraded to Neutral from Outperform at Wedbush
08/06/21 BMO Capital
TCR2 Therapeutics price target lowered to $44 from $53 at BMO Capital
06/24/21 Goldman Sachs
TCR2 Therapeutics initiated with a Buy at Goldman Sachs
06/11/21 BMO Capital
TCR2 Therapeutics coverage transferred at BMO Capital
VERU Veru
$8.94 /

+0.17 (+1.94%)

04/13/21 Jefferies
Veru initiated with a Buy at Jefferies
02/11/21 Oppenheimer
Veru price target raised to $24 from $19 at Oppenheimer
02/11/21 H.C. Wainwright
Veru price target raised to $22 from $17 at H.C. Wainwright
02/09/21 H.C. Wainwright
Veru price target raised to $17 from $12 at H.C. Wainwright
VBLT VBL Therapeutics
$2.32 /

-0.035 (-1.49%)

08/30/21 Roth Capital
Roth bullish on VBL Therapeutics as U.S. Phase 3 OVAL trial enrollment resumes
06/15/21 Roth Capital
Roth does not see material change to VBL readout timelines
06/03/21 Roth Capital
Roth Capital ups VBL Therapeutics target to $7 on OVAL primary endpoint update
05/18/21 Guggenheim
VBL Therapeutics initiated with a Buy at Guggenheim
VTRS Viatris
$13.57 /

-0.13 (-0.95%)

06/15/21 Citi
Viatris initiated with a Neutral at Citi
04/06/21 RBC Capital
Viatris transferred with an Outperform at RBC Capital
03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
03/12/21 Piper Sandler
Viatris price target lowered to $16 from $17 at Piper Sandler
NVS Novartis
$83.49 /

-0.88 (-1.04%)

04:39 Today Deutsche Bank
Novartis downgraded to Sell from Hold at Deutsche Bank
09/07/21 Wedbush
Wedbush downgrades Xoma to Neutral, cuts target to $22
07/28/21 JPMorgan
Novartis price target raised to CHF 84 from CHF 80 at JPMorgan
VTRS Viatris
$13.57 /

-0.13 (-0.95%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

VBLT VBL Therapeutics
$2.32 /

-0.035 (-1.49%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

GH Guardant Health
$132.01 /

+5.01 (+3.94%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

DCPH Deciphera
$33.08 /

+1.45 (+4.58%)

CALA Calithera Biosciences
$2.25 /

+0.2 (+9.76%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

AYLA Ayala Pharmaceuticals
$12.25 /

-0.01 (-0.08%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

  • 08
    Jul
  • 03
    Jun
  • 04
    May
  • 09
    Apr
  • 01
    Mar
  • 18
    Feb
  • 20
    Jan
  • 02
    Dec
  • 02
    Dec
  • 19
    Nov
  • 13
    Nov
  • 07
    Oct
TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GMAB Genmab
$43.10 /

+0.845 (+2.00%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

GH Guardant Health
$132.01 /

+5.01 (+3.94%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

VTRS Viatris
$13.57 /

-0.13 (-0.95%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

Yesterday
Conference/Events
European Society for Medical Oncology to hold a virtual meeting » 04:55
09/19/21
09/19
04:55
09/19/21
04:55
ABBV

AbbVie

$107.75 /

-0.33 (-0.31%)

, AYLA

Ayala Pharmaceuticals

$12.25 /

-0.01 (-0.08%)

, DCPH

Deciphera

$33.08 /

+1.45 (+4.58%)

, GMAB

Genmab

$43.10 /

+0.845 (+2.00%)

, LPTX

Leap Therapeutics

$2.65 /

+0.13 (+5.16%)

, ORIC

Oric Pharmaceuticals

$25.20 /

+0.99 (+4.09%)

, SYNH

Syneos Health

$94.34 /

+0.55 (+0.59%)

, BGNE

BeiGene

$403.60 /

+18.32 (+4.75%)

, BMY

Bristol-Myers

$61.32 /

+0.1 (+0.16%)

, BYSI

BeyondSpring

$23.00 /

+0.47 (+2.09%)

, CALA

Calithera Biosciences

$2.25 /

+0.2 (+9.76%)

, GILD

Gilead

$71.61 /

+0.34 (+0.48%)

, GH

Guardant Health

$132.01 /

+5.01 (+3.94%)

, LLY

Eli Lilly

$230.17 /

-0.78 (-0.34%)

, IPSEY

Ipsen

$23.92 /

-0.395 (-1.62%)

, EXAS

Exact Sciences

$108.29 /

+5.47 (+5.32%)

, IDYA

Ideaya Biosciences

$26.90 /

+0.9 (+3.46%)

, GSK

GlaxoSmithKline

$38.94 /

-0.16 (-0.41%)

, RHHBY

Roche

$46.07 /

-0.75 (-1.60%)

, REGN

Regeneron

$651.38 /

-2.3 (-0.35%)

, PFE

Pfizer

$43.89 /

-0.57 (-1.28%)

, TAK

Takeda Pharmaceutical

$17.16 /

-0.045 (-0.26%)

, TMO

Thermo Fisher

$596.98 /

+36.11 (+6.44%)

, TCRR

TCR2 Therapeutics

$10.00 /

-5.715 (-36.38%)

, VERU

Veru

$8.94 /

+0.17 (+1.94%)

, VBLT

VBL Therapeutics

$2.32 /

-0.035 (-1.49%)

, VTRS

Viatris

$13.57 /

-0.13 (-0.95%)

, NVS

Novartis

$83.49 /

-0.88 (-1.04%)

ESMO 2021 Virtual…

ESMO 2021 Virtual Congress will be held on September 16-21. Webcast Link

ShowHide Related Items >><<
VTRS Viatris
$13.57 /

-0.13 (-0.95%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

VBLT VBL Therapeutics
$2.32 /

-0.035 (-1.49%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

IPSEY Ipsen
$23.92 /

-0.395 (-1.62%)

IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GMAB Genmab
$43.10 /

+0.845 (+2.00%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

GH Guardant Health
$132.01 /

+5.01 (+3.94%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

DCPH Deciphera
$33.08 /

+1.45 (+4.58%)

CALA Calithera Biosciences
$2.25 /

+0.2 (+9.76%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

AYLA Ayala Pharmaceuticals
$12.25 /

-0.01 (-0.08%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

09/14/21 Barclays
Regenxbio price target raised to $82 from $79 at Barclays
09/13/21 Chardan
Regenxbio pact with AbbVie accelerates RGX-314 'value capture,' says Chardan
09/08/21 JPMorgan
AbbVie offers 'best risk/reward story in the group,' says JPMorgan
09/07/21 Morgan Stanley
Morgan Stanley cuts Vertex Pharmaceuticals to Underweight amid AbbVie overhang
AYLA Ayala Pharmaceuticals
$12.25 /

-0.01 (-0.08%)

07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with Buy, $29 target at Ladenburg
07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with a Buy at Ladenburg
12/07/20
Fly Intel: Top five analyst initiations
12/07/20 Roth Capital
Ayala Pharmaceuticals initiated with a Buy at Roth Capital
DCPH Deciphera
$33.08 /

+1.45 (+4.58%)

08/04/21 H.C. Wainwright
Deciphera price target lowered to $70 from $75 at H.C. Wainwright
05/05/21 Barclays
Deciphera price target lowered to $65 from $70 at Barclays
05/05/21 H.C. Wainwright
Deciphera price target lowered to $75 from $80 at H.C. Wainwright
05/05/21 Piper Sandler
Deciphera price target lowered to $60 from $75 at Piper Sandler
GMAB Genmab
$43.10 /

+0.845 (+2.00%)

09/16/21
Fly Intel: Top five analyst downgrades
09/16/21 Jefferies
Genmab downgraded to Hold from Buy at Jefferies
09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley cuts Genmab to Underweight amid high investor expectations
LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

09/16/21 Piper Sandler
Leap data show 'very favorable early signal,' says Piper Sandler
09/13/21 Raymond James
Leap Therapeutics price target raised to $4 from $3 at Raymond James
09/13/21 Piper Sandler
Leap combo sees 'strong' early response rate, says Piper Sandler
06/03/21 Baird
Leap Therapeutics transferred with Outperform at Baird
ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy after tumor data at Citi
07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy from Neutral at Citi
03/25/21 H.C. Wainwright
Oric Pharmaceuticals price target raised to $54 from $52 at H.C. Wainwright
01/25/21 Citi
Oric Pharmaceuticals downgraded to Neutral from Buy at Citi
SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

08/04/21 Credit Suisse
Syneos Health assumed with an Outperform at Credit Suisse
07/13/21 Barclays
Syneos Health price target raised to $102 from $90 at Barclays
06/02/21 Truist
Syneos Health price target raised to $104 from $88 at Truist
04/30/21 Mizuho
Syneos Health price target raised to $90 from $82 at Mizuho
BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

09/08/21 Baird
BeyondSpring initiated with an Outperform at Baird
08/04/21 Evercore ISI
BeyondSpring price target raised to $95 from $30 at Evercore ISI
08/04/21 William Blair
BeyondSpring may have new standard of care in lung cancer, says William Blair
08/04/21 H.C. Wainwright
Wainwright upgrades BeyondSpring with $100 target on lung cancer data
CALA Calithera Biosciences
$2.25 /

+0.2 (+9.76%)

01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform at SVB Leerink
01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform from Outperform at SVB Leerink
01/05/21 Citi
Calithera Biosciences price target lowered to $5 from $10 at Citi
01/05/21 H.C. Wainwright
Calithera Biosciences price target lowered to $4 from $9.50 at H.C. Wainwright
GILD Gilead
$71.61 /

+0.34 (+0.48%)

07/30/21 BMO Capital
Gilead price target raised to $72 from $67 at BMO Capital
07/30/21 RBC Capital
Gilead price target raised to $84 from $81 at RBC Capital
06/29/21 Jefferies
Gilead data should move Yescarta up to second line in DLBCL, says Jefferies
GH Guardant Health
$132.01 /

+5.01 (+3.94%)

08/09/21 Canaccord
Guardant Health price target lowered to $180 from $195 at Canaccord
06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Guardant Health initiated with a Market Perform at Raymond James
LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

09/02/21 SVB Leerink
AbbVie price target lowered to $142 from $148 at SVB Leerink
08/30/21 Cowen
Eli Lilly price target raised to $300 from $250 at Cowen
08/30/21 Citi
Lexicon price target raised to $20 from $13 at Citi
IPSEY Ipsen
$23.92 /

-0.395 (-1.62%)

08/16/21 Morgan Stanley
Ipsen price target lowered to EUR 88 from EUR 92 at Morgan Stanley
08/03/21 Morgan Stanley
Ipsen price target raised to EUR 92 from EUR 85 at Morgan Stanley
08/02/21 Societe Generale
Ipsen price target raised to EUR 101 from EUR 90 at Societe Generale
07/30/21 Credit Suisse
Ipsen price target raised to EUR 90 from EUR 75 at Credit Suisse
EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
09/15/21 Canaccord
Exact Sciences progress in MRD space a positive, says Canaccord
09/01/21 Baird
UnitedHealth update to CRC screening coverage not a surprise, says Baird
IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

06/03/21 Baird
Ideaya Biosciences assumed with an Outperform at Baird
04/22/21 Roth Capital
Ideaya Biosciences price target raised to $38 from $31 at Roth Capital
04/19/21 H.C. Wainwright
Ideaya Biosciences price target raised to $35 from $29 at H.C. Wainwright
04/16/21 Roth Capital
Ideaya Biosciences price target raised to $31 from $23 at Roth Capital
GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

08/26/21 UBS
GlaxoSmithKline price target raised to 1,540 GBp from 1,485 GBp at UBS
08/20/21 JPMorgan
GlaxoSmithKline price target raised to 1,500 GBp from 1,300 GBp at JPMorgan
08/19/21 Berenberg
GlaxoSmithKline price target raised to 1,625 GBp from 1,570 GBp at Berenberg
RHHBY Roche
$46.07 /

-0.75 (-1.60%)

09/07/21 UBS
Roche price target raised to CHF 350 from CHF 345 at UBS
08/02/21 JPMorgan
Roche price target raised to CHF 360 from CHF 310 at JPMorgan
07/27/21 Societe Generale
Roche price target raised to CHF 353 from CHF 340 at Societe Generale
REGN Regeneron
$651.38 /

-2.3 (-0.35%)

09/15/21 Cantor Fitzgerald
Regeneron price target raised to $700 from $670 at Cantor Fitzgerald
09/15/21 H.C. Wainwright
Regeneron price target raised to $831 from $787 at H.C. Wainwright
09/15/21 Piper Sandler
Regeneron price target raised to $690 from $675 at Piper Sandler
09/09/21
Fly Intel: Top five analyst initiations
PFE Pfizer
$43.89 /

-0.57 (-1.28%)

09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

08/03/21 Piper Sandler
Arcturus strength attributable to large pharma's interest in mRNA, says Piper
04/27/21 Chardan
LogicBio collaborations may signal recognition of platforms, says Chardan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

08/04/21 Credit Suisse
Thermo Fisher assumed with an Outperform at Credit Suisse
08/04/21 Argus
Thermo Fisher price target raised to $600 from $530 at Argus
07/29/21 Cowen
Thermo Fisher price target raised to $560 from $525 at Cowen
07/29/21 BTIG
Thermo Fisher price target raised to $610 from $590 at BTIG
TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

09/17/21 Wedbush
TCR2 Therapeutics downgraded to Neutral from Outperform at Wedbush
08/06/21 BMO Capital
TCR2 Therapeutics price target lowered to $44 from $53 at BMO Capital
06/24/21 Goldman Sachs
TCR2 Therapeutics initiated with a Buy at Goldman Sachs
06/11/21 BMO Capital
TCR2 Therapeutics coverage transferred at BMO Capital
VERU Veru
$8.94 /

+0.17 (+1.94%)

04/13/21 Jefferies
Veru initiated with a Buy at Jefferies
02/11/21 Oppenheimer
Veru price target raised to $24 from $19 at Oppenheimer
02/11/21 H.C. Wainwright
Veru price target raised to $22 from $17 at H.C. Wainwright
02/09/21 H.C. Wainwright
Veru price target raised to $17 from $12 at H.C. Wainwright
VBLT VBL Therapeutics
$2.32 /

-0.035 (-1.49%)

08/30/21 Roth Capital
Roth bullish on VBL Therapeutics as U.S. Phase 3 OVAL trial enrollment resumes
06/15/21 Roth Capital
Roth does not see material change to VBL readout timelines
06/03/21 Roth Capital
Roth Capital ups VBL Therapeutics target to $7 on OVAL primary endpoint update
05/18/21 Guggenheim
VBL Therapeutics initiated with a Buy at Guggenheim
VTRS Viatris
$13.57 /

-0.13 (-0.95%)

06/15/21 Citi
Viatris initiated with a Neutral at Citi
04/06/21 RBC Capital
Viatris transferred with an Outperform at RBC Capital
03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
03/12/21 Piper Sandler
Viatris price target lowered to $16 from $17 at Piper Sandler
NVS Novartis
$83.49 /

-0.88 (-1.04%)

09/07/21 Wedbush
Wedbush downgrades Xoma to Neutral, cuts target to $22
07/28/21 JPMorgan
Novartis price target raised to CHF 84 from CHF 80 at JPMorgan
07/27/21 Jefferies
Point Biopharma initiated with a Hold at Jefferies
VTRS Viatris
$13.57 /

-0.13 (-0.95%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

VBLT VBL Therapeutics
$2.32 /

-0.035 (-1.49%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

GH Guardant Health
$132.01 /

+5.01 (+3.94%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

DCPH Deciphera
$33.08 /

+1.45 (+4.58%)

CALA Calithera Biosciences
$2.25 /

+0.2 (+9.76%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

AYLA Ayala Pharmaceuticals
$12.25 /

-0.01 (-0.08%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

  • 08
    Jul
  • 03
    Jun
  • 04
    May
  • 09
    Apr
  • 01
    Mar
  • 18
    Feb
  • 20
    Jan
  • 02
    Dec
  • 02
    Dec
  • 19
    Nov
  • 13
    Nov
  • 07
    Oct
TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GMAB Genmab
$43.10 /

+0.845 (+2.00%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

GH Guardant Health
$132.01 /

+5.01 (+3.94%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

VTRS Viatris
$13.57 /

-0.13 (-0.95%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

Saturday
On The Fly
Opening Day: Sports analytics company Sportradar drops in trading debut » 10:34
09/18/21
09/18
10:34
09/18/21
10:34
FORG

ForgeRock

$45.46 /

+8.86 (+24.21%)

, HZON

Horizon Acquisition Corp. II

$9.80 /

+0.04 (+0.41%)

, ACT

Enact Holdings

$20.01 /

-0.41 (-2.01%)

, ONON

On Holding

$38.95 /

+1.45 (+3.87%)

, DICE

Dice Therapeutics

$37.73 /

+1.93 (+5.39%)

, DH

Definitive Healthcare

$48.99 /

+1.87 (+3.97%)

, BROS

Dutch Bros

$43.56 /

-4.42 (-9.21%)

, TWKS

Thoughtworks

$34.06 /

+2.7 (+8.61%)

, PRCT

Procept BioRobotics

$40.03 /

+3.77 (+10.40%)

, KTTA

Pasithea Therapeutics

$3.14 /

-0.23 (-6.82%)

, SRAD

Sportradar

$27.01 /

+0.22 (+0.82%)

, RNXT

RenovoRx

$7.46 /

-0.45 (-5.69%)

, SQL

SeqLL

$3.91 /

+0.09 (+2.36%)

, DDI

DoubleDown

$17.50 /

+0.22 (+1.27%)

, QNIU

Qiniu

/

+

, CMSL

Camposol

/

+

, SPRK

Spark Education

/

+

, SCAN

Perspectum Group

/

+

, AUTH

Authentic Brands Group

$8.01 /

+ (+0.00%)

, ARBK

Argo Blockchain

/

+

, WRBY

Warby Parker

/

+

, TOST

Toast

/

+

, HLTH

Cue Health

/

+

, ALVU

Allvue

/

+

, BIRD

Allbirds

/

+

, GTLB

GitLab

/

+

, KETR

Keter

/

+

, AMZN

Amazon.com

$3,461.96 /

-25.76 (-0.74%)

, F

Ford

$13.56 /

+0.16 (+1.19%)

, BABA

Alibaba

$160.00 /

+3.74 (+2.39%)

, EZFL

EzFill

$4.57 /

-0.62 (-11.95%)

The Switzerland-based…

ShowHide Related Items >><<
RNXT RenovoRx
$7.46 /

-0.45 (-5.69%)

ONON On Holding
$38.95 /

+1.45 (+3.87%)

FORG ForgeRock
$45.46 /

+8.86 (+24.21%)

F Ford
$13.56 /

+0.16 (+1.19%)

DDI DoubleDown
$17.50 /

+0.22 (+1.27%)

BROS Dutch Bros
$43.56 /

-4.42 (-9.21%)

BABA Alibaba
$160.00 /

+3.74 (+2.39%)

AUTH Authentic Brands Group
$8.01 /

+ (+0.00%)

AMZN Amazon.com
$3,461.96 /

-25.76 (-0.74%)

ALVU Allvue
/

+

FORG ForgeRock
$45.46 /

+8.86 (+24.21%)

HZON Horizon Acquisition Corp. II
$9.80 /

+0.04 (+0.41%)

ACT Enact Holdings
$20.01 /

-0.41 (-2.01%)

ONON On Holding
$38.95 /

+1.45 (+3.87%)

09/17/21 Citi
Deckers Brands portfolio being 'significantly undervalued,' says Citi
DICE Dice Therapeutics
$37.73 /

+1.93 (+5.39%)

DH Definitive Healthcare
$48.99 /

+1.87 (+3.97%)

BROS Dutch Bros
$43.56 /

-4.42 (-9.21%)

TWKS Thoughtworks
$34.06 /

+2.7 (+8.61%)

PRCT Procept BioRobotics
$40.03 /

+3.77 (+10.40%)

KTTA Pasithea Therapeutics
$3.14 /

-0.23 (-6.82%)

SRAD Sportradar
$27.01 /

+0.22 (+0.82%)

RNXT RenovoRx
$7.46 /

-0.45 (-5.69%)

SQL SeqLL
$3.91 /

+0.09 (+2.36%)

DDI DoubleDown
$17.50 /

+0.22 (+1.27%)

QNIU Qiniu
/

+

CMSL Camposol
/

+

SPRK Spark Education
/

+

SCAN Perspectum Group
/

+

AUTH Authentic Brands Group
$8.01 /

+ (+0.00%)

ARBK Argo Blockchain
/

+

WRBY Warby Parker
/

+

TOST Toast
/

+

HLTH Cue Health
/

+

ALVU Allvue
/

+

BIRD Allbirds
/

+

GTLB GitLab
/

+

KETR Keter
/

+

AMZN Amazon.com
$3,461.96 /

-25.76 (-0.74%)

09/14/21 Evercore ISI
Amazon price target raised to $4,700 from $4,200 at Evercore ISI
09/13/21
Fly Intel: Top five analyst initiations
09/13/21 Goldman Sachs
Amazon.com initiated with a Buy at Goldman Sachs
09/10/21 BofA
Affirm price target raised to $119 from $82 at BofA
F Ford
$13.56 /

+0.16 (+1.19%)

09/08/21 Benchmark
Worst of chip shortage could be over for Ford, says Benchmark
07/16/21 BofA
Ford price target raised to $18 from $17 at BofA
06/29/21 UBS
Ford price target raised to $16 from $13 at UBS
06/22/21 Barclays
Ford price target raised to $17 from $15 at Barclays
BABA Alibaba
$160.00 /

+3.74 (+2.39%)

09/15/21 Stifel
Alibaba price target lowered to $210 from $260 at Stifel
09/06/21 KGI Securities
Alibaba initiated with a Neutral at KGI Securities
08/20/21 Erste Group
Alibaba downgraded to Sell from Hold at Erste Group
08/05/21 Susquehanna
Alibaba price target lowered to $310 from $350 at Susquehanna
EZFL EzFill
$4.57 /

-0.62 (-11.95%)

F Ford
$13.56 /

+0.16 (+1.19%)

BABA Alibaba
$160.00 /

+3.74 (+2.39%)

AMZN Amazon.com
$3,461.96 /

-25.76 (-0.74%)

  • 24
    Sep
  • 23
    Sep
  • 15
    Sep
  • 22
    Sep
  • 16
    Sep
  • 15
    Sep
  • 15
    Sep
  • 29
    Sep
  • 15
    Sep
  • 15
    Sep
  • 15
    Sep
  • 15
    Sep
  • 16
    Sep
  • 15
    Sep
  • 14
    Sep
  • 27
    Aug
  • 26
    Aug
  • 31
    Aug
  • 16
    Jul
  • 13
    May
SRAD Sportradar
$27.01 /

+0.22 (+0.82%)

HZON Horizon Acquisition Corp. II
$9.80 /

+0.04 (+0.41%)

F Ford
$13.56 /

+0.16 (+1.19%)

BABA Alibaba
$160.00 /

+3.74 (+2.39%)

AUTH Authentic Brands Group
$8.01 /

+ (+0.00%)

AMZN Amazon.com
$3,461.96 /

-25.76 (-0.74%)

PRCT Procept BioRobotics
$40.03 /

+3.77 (+10.40%)

ONON On Holding
$38.95 /

+1.45 (+3.87%)

HZON Horizon Acquisition Corp. II
$9.80 /

+0.04 (+0.41%)

F Ford
$13.56 /

+0.16 (+1.19%)

BABA Alibaba
$160.00 /

+3.74 (+2.39%)

AMZN Amazon.com
$3,461.96 /

-25.76 (-0.74%)

HZON Horizon Acquisition Corp. II
$9.80 /

+0.04 (+0.41%)

F Ford
$13.56 /

+0.16 (+1.19%)

BABA Alibaba
$160.00 /

+3.74 (+2.39%)

AMZN Amazon.com
$3,461.96 /

-25.76 (-0.74%)

Conference/Events
European Society for Medical Oncology to hold a virtual meeting » 04:55
09/18/21
09/18
04:55
09/18/21
04:55
ABBV

AbbVie

$107.75 /

-0.33 (-0.31%)

, AYLA

Ayala Pharmaceuticals

$12.25 /

-0.01 (-0.08%)

, DCPH

Deciphera

$33.08 /

+1.45 (+4.58%)

, GMAB

Genmab

$43.10 /

+0.845 (+2.00%)

, LPTX

Leap Therapeutics

$2.65 /

+0.13 (+5.16%)

, ORIC

Oric Pharmaceuticals

$25.20 /

+0.99 (+4.09%)

, SYNH

Syneos Health

$94.34 /

+0.55 (+0.59%)

, BGNE

BeiGene

$403.60 /

+18.32 (+4.75%)

, BMY

Bristol-Myers

$61.32 /

+0.1 (+0.16%)

, BYSI

BeyondSpring

$23.00 /

+0.47 (+2.09%)

, CALA

Calithera Biosciences

$2.25 /

+0.2 (+9.76%)

, GILD

Gilead

$71.61 /

+0.34 (+0.48%)

, GH

Guardant Health

$132.01 /

+5.01 (+3.94%)

, LLY

Eli Lilly

$230.17 /

-0.78 (-0.34%)

, IPSEY

Ipsen

$23.92 /

-0.395 (-1.62%)

, EXAS

Exact Sciences

$108.29 /

+5.47 (+5.32%)

, IDYA

Ideaya Biosciences

$26.90 /

+0.9 (+3.46%)

, GSK

GlaxoSmithKline

$38.94 /

-0.16 (-0.41%)

, RHHBY

Roche

$46.07 /

-0.75 (-1.60%)

, REGN

Regeneron

$651.38 /

-2.3 (-0.35%)

, PFE

Pfizer

$43.89 /

-0.57 (-1.28%)

, TAK

Takeda Pharmaceutical

$17.16 /

-0.045 (-0.26%)

, TMO

Thermo Fisher

$596.98 /

+36.11 (+6.44%)

, TCRR

TCR2 Therapeutics

$10.00 /

-5.715 (-36.38%)

, VERU

Veru

$8.94 /

+0.17 (+1.94%)

, VBLT

VBL Therapeutics

$2.32 /

-0.035 (-1.49%)

, VTRS

Viatris

$13.57 /

-0.13 (-0.95%)

, NVS

Novartis

$83.49 /

-0.88 (-1.04%)

ESMO 2021 Virtual…

ESMO 2021 Virtual Congress will be held on September 16-21. Webcast Link

ShowHide Related Items >><<
VTRS Viatris
$13.57 /

-0.13 (-0.95%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

VBLT VBL Therapeutics
$2.32 /

-0.035 (-1.49%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

IPSEY Ipsen
$23.92 /

-0.395 (-1.62%)

IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GMAB Genmab
$43.10 /

+0.845 (+2.00%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

GH Guardant Health
$132.01 /

+5.01 (+3.94%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

DCPH Deciphera
$33.08 /

+1.45 (+4.58%)

CALA Calithera Biosciences
$2.25 /

+0.2 (+9.76%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

AYLA Ayala Pharmaceuticals
$12.25 /

-0.01 (-0.08%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

09/14/21 Barclays
Regenxbio price target raised to $82 from $79 at Barclays
09/13/21 Chardan
Regenxbio pact with AbbVie accelerates RGX-314 'value capture,' says Chardan
09/08/21 JPMorgan
AbbVie offers 'best risk/reward story in the group,' says JPMorgan
09/07/21 Morgan Stanley
Morgan Stanley cuts Vertex Pharmaceuticals to Underweight amid AbbVie overhang
AYLA Ayala Pharmaceuticals
$12.25 /

-0.01 (-0.08%)

07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with Buy, $29 target at Ladenburg
07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with a Buy at Ladenburg
12/07/20
Fly Intel: Top five analyst initiations
12/07/20 Roth Capital
Ayala Pharmaceuticals initiated with a Buy at Roth Capital
DCPH Deciphera
$33.08 /

+1.45 (+4.58%)

08/04/21 H.C. Wainwright
Deciphera price target lowered to $70 from $75 at H.C. Wainwright
05/05/21 Barclays
Deciphera price target lowered to $65 from $70 at Barclays
05/05/21 H.C. Wainwright
Deciphera price target lowered to $75 from $80 at H.C. Wainwright
05/05/21 Piper Sandler
Deciphera price target lowered to $60 from $75 at Piper Sandler
GMAB Genmab
$43.10 /

+0.845 (+2.00%)

09/16/21
Fly Intel: Top five analyst downgrades
09/16/21 Jefferies
Genmab downgraded to Hold from Buy at Jefferies
09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley cuts Genmab to Underweight amid high investor expectations
LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

09/16/21 Piper Sandler
Leap data show 'very favorable early signal,' says Piper Sandler
09/13/21 Raymond James
Leap Therapeutics price target raised to $4 from $3 at Raymond James
09/13/21 Piper Sandler
Leap combo sees 'strong' early response rate, says Piper Sandler
06/03/21 Baird
Leap Therapeutics transferred with Outperform at Baird
ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy after tumor data at Citi
07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy from Neutral at Citi
03/25/21 H.C. Wainwright
Oric Pharmaceuticals price target raised to $54 from $52 at H.C. Wainwright
01/25/21 Citi
Oric Pharmaceuticals downgraded to Neutral from Buy at Citi
SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

08/04/21 Credit Suisse
Syneos Health assumed with an Outperform at Credit Suisse
07/13/21 Barclays
Syneos Health price target raised to $102 from $90 at Barclays
06/02/21 Truist
Syneos Health price target raised to $104 from $88 at Truist
04/30/21 Mizuho
Syneos Health price target raised to $90 from $82 at Mizuho
BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

09/08/21 Baird
BeyondSpring initiated with an Outperform at Baird
08/04/21 Evercore ISI
BeyondSpring price target raised to $95 from $30 at Evercore ISI
08/04/21 William Blair
BeyondSpring may have new standard of care in lung cancer, says William Blair
08/04/21 H.C. Wainwright
Wainwright upgrades BeyondSpring with $100 target on lung cancer data
CALA Calithera Biosciences
$2.25 /

+0.2 (+9.76%)

01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform at SVB Leerink
01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform from Outperform at SVB Leerink
01/05/21 Citi
Calithera Biosciences price target lowered to $5 from $10 at Citi
01/05/21 H.C. Wainwright
Calithera Biosciences price target lowered to $4 from $9.50 at H.C. Wainwright
GILD Gilead
$71.61 /

+0.34 (+0.48%)

07/30/21 BMO Capital
Gilead price target raised to $72 from $67 at BMO Capital
07/30/21 RBC Capital
Gilead price target raised to $84 from $81 at RBC Capital
06/29/21 Jefferies
Gilead data should move Yescarta up to second line in DLBCL, says Jefferies
GH Guardant Health
$132.01 /

+5.01 (+3.94%)

08/09/21 Canaccord
Guardant Health price target lowered to $180 from $195 at Canaccord
06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Guardant Health initiated with a Market Perform at Raymond James
LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

09/02/21 SVB Leerink
AbbVie price target lowered to $142 from $148 at SVB Leerink
08/30/21 Cowen
Eli Lilly price target raised to $300 from $250 at Cowen
08/30/21 Citi
Lexicon price target raised to $20 from $13 at Citi
IPSEY Ipsen
$23.92 /

-0.395 (-1.62%)

08/16/21 Morgan Stanley
Ipsen price target lowered to EUR 88 from EUR 92 at Morgan Stanley
08/03/21 Morgan Stanley
Ipsen price target raised to EUR 92 from EUR 85 at Morgan Stanley
08/02/21 Societe Generale
Ipsen price target raised to EUR 101 from EUR 90 at Societe Generale
07/30/21 Credit Suisse
Ipsen price target raised to EUR 90 from EUR 75 at Credit Suisse
EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
09/15/21 Canaccord
Exact Sciences progress in MRD space a positive, says Canaccord
09/01/21 Baird
UnitedHealth update to CRC screening coverage not a surprise, says Baird
IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

06/03/21 Baird
Ideaya Biosciences assumed with an Outperform at Baird
04/22/21 Roth Capital
Ideaya Biosciences price target raised to $38 from $31 at Roth Capital
04/19/21 H.C. Wainwright
Ideaya Biosciences price target raised to $35 from $29 at H.C. Wainwright
04/16/21 Roth Capital
Ideaya Biosciences price target raised to $31 from $23 at Roth Capital
GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

08/26/21 UBS
GlaxoSmithKline price target raised to 1,540 GBp from 1,485 GBp at UBS
08/20/21 JPMorgan
GlaxoSmithKline price target raised to 1,500 GBp from 1,300 GBp at JPMorgan
08/19/21 Berenberg
GlaxoSmithKline price target raised to 1,625 GBp from 1,570 GBp at Berenberg
RHHBY Roche
$46.07 /

-0.75 (-1.60%)

09/07/21 UBS
Roche price target raised to CHF 350 from CHF 345 at UBS
08/02/21 JPMorgan
Roche price target raised to CHF 360 from CHF 310 at JPMorgan
07/27/21 Societe Generale
Roche price target raised to CHF 353 from CHF 340 at Societe Generale
REGN Regeneron
$651.38 /

-2.3 (-0.35%)

09/15/21 Cantor Fitzgerald
Regeneron price target raised to $700 from $670 at Cantor Fitzgerald
09/15/21 H.C. Wainwright
Regeneron price target raised to $831 from $787 at H.C. Wainwright
09/15/21 Piper Sandler
Regeneron price target raised to $690 from $675 at Piper Sandler
09/09/21
Fly Intel: Top five analyst initiations
PFE Pfizer
$43.89 /

-0.57 (-1.28%)

09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

08/03/21 Piper Sandler
Arcturus strength attributable to large pharma's interest in mRNA, says Piper
04/27/21 Chardan
LogicBio collaborations may signal recognition of platforms, says Chardan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

08/04/21 Credit Suisse
Thermo Fisher assumed with an Outperform at Credit Suisse
08/04/21 Argus
Thermo Fisher price target raised to $600 from $530 at Argus
07/29/21 Cowen
Thermo Fisher price target raised to $560 from $525 at Cowen
07/29/21 BTIG
Thermo Fisher price target raised to $610 from $590 at BTIG
TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

09/17/21 Wedbush
TCR2 Therapeutics downgraded to Neutral from Outperform at Wedbush
08/06/21 BMO Capital
TCR2 Therapeutics price target lowered to $44 from $53 at BMO Capital
06/24/21 Goldman Sachs
TCR2 Therapeutics initiated with a Buy at Goldman Sachs
06/11/21 BMO Capital
TCR2 Therapeutics coverage transferred at BMO Capital
VERU Veru
$8.94 /

+0.17 (+1.94%)

04/13/21 Jefferies
Veru initiated with a Buy at Jefferies
02/11/21 Oppenheimer
Veru price target raised to $24 from $19 at Oppenheimer
02/11/21 H.C. Wainwright
Veru price target raised to $22 from $17 at H.C. Wainwright
02/09/21 H.C. Wainwright
Veru price target raised to $17 from $12 at H.C. Wainwright
VBLT VBL Therapeutics
$2.32 /

-0.035 (-1.49%)

08/30/21 Roth Capital
Roth bullish on VBL Therapeutics as U.S. Phase 3 OVAL trial enrollment resumes
06/15/21 Roth Capital
Roth does not see material change to VBL readout timelines
06/03/21 Roth Capital
Roth Capital ups VBL Therapeutics target to $7 on OVAL primary endpoint update
05/18/21 Guggenheim
VBL Therapeutics initiated with a Buy at Guggenheim
VTRS Viatris
$13.57 /

-0.13 (-0.95%)

06/15/21 Citi
Viatris initiated with a Neutral at Citi
04/06/21 RBC Capital
Viatris transferred with an Outperform at RBC Capital
03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
03/12/21 Piper Sandler
Viatris price target lowered to $16 from $17 at Piper Sandler
NVS Novartis
$83.49 /

-0.88 (-1.04%)

09/07/21 Wedbush
Wedbush downgrades Xoma to Neutral, cuts target to $22
07/28/21 JPMorgan
Novartis price target raised to CHF 84 from CHF 80 at JPMorgan
07/27/21 Jefferies
Point Biopharma initiated with a Hold at Jefferies
VTRS Viatris
$13.57 /

-0.13 (-0.95%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

VBLT VBL Therapeutics
$2.32 /

-0.035 (-1.49%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

GH Guardant Health
$132.01 /

+5.01 (+3.94%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

DCPH Deciphera
$33.08 /

+1.45 (+4.58%)

CALA Calithera Biosciences
$2.25 /

+0.2 (+9.76%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

AYLA Ayala Pharmaceuticals
$12.25 /

-0.01 (-0.08%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

  • 08
    Jul
  • 03
    Jun
  • 04
    May
  • 09
    Apr
  • 01
    Mar
  • 18
    Feb
  • 20
    Jan
  • 02
    Dec
  • 02
    Dec
  • 19
    Nov
  • 13
    Nov
  • 07
    Oct
TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GMAB Genmab
$43.10 /

+0.845 (+2.00%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

GH Guardant Health
$132.01 /

+5.01 (+3.94%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

VTRS Viatris
$13.57 /

-0.13 (-0.95%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

Friday
Conference/Events
European Society for Medical Oncology to hold a virtual meeting » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
ABBV

AbbVie

$108.08 /

+0.29 (+0.27%)

, AYLA

Ayala Pharmaceuticals

$12.26 /

-1.76 (-12.55%)

, DCPH

Deciphera

$31.77 /

+0.72 (+2.32%)

, GMAB

Genmab

$42.26 /

-0.575 (-1.34%)

, LPTX

Leap Therapeutics

$2.52 /

+0.57 (+29.23%)

, ORIC

Oric Pharmaceuticals

$24.49 /

-0.31 (-1.25%)

, SYNH

Syneos Health

$93.78 /

+0.07 (+0.07%)

, BGNE

BeiGene

$385.26 /

+10.94 (+2.92%)

, BMY

Bristol-Myers

$61.22 /

-0.78 (-1.26%)

, BYSI

BeyondSpring

$22.50 /

-0.48 (-2.09%)

, CALA

Calithera Biosciences

$2.05 /

-0.04 (-1.91%)

, GILD

Gilead

$71.32 /

-0.45 (-0.63%)

, GH

Guardant Health

$127.00 /

-0.01 (-0.01%)

, LLY

Eli Lilly

$230.95 /

-2.72 (-1.16%)

, IPSEY

Ipsen

$24.32 /

+0.23 (+0.95%)

, EXAS

Exact Sciences

$102.81 /

-1.83 (-1.75%)

, IDYA

Ideaya Biosciences

$25.90 /

-0.1 (-0.38%)

, GSK

GlaxoSmithKline

$39.10 /

-0.11 (-0.28%)

, RHHBY

Roche

$46.82 /

-0.04 (-0.09%)

, REGN

Regeneron

$652.73 /

+2.13 (+0.33%)

, PFE

Pfizer

$44.46 /

-0.31 (-0.69%)

, TAK

Takeda Pharmaceutical

$17.21 /

+0.205 (+1.21%)

, TMO

Thermo Fisher

$560.75 /

-2.085 (-0.37%)

, TCRR

TCR2 Therapeutics

$15.71 /

-0.51 (-3.14%)

, VERU

Veru

$8.76 /

-0.04 (-0.45%)

, VBLT

VBL Therapeutics

$2.35 /

+0.055 (+2.40%)

, VTRS

Viatris

$13.70 /

-0.03 (-0.22%)

, NVS

Novartis

$84.37 /

-0.695 (-0.82%)

ESMO 2021 Virtual…

ESMO 2021 Virtual Congress will be held on September 16-21. Webcast Link

ShowHide Related Items >><<
VTRS Viatris
$13.70 /

-0.03 (-0.22%)

VERU Veru
$8.76 /

-0.04 (-0.45%)

VBLT VBL Therapeutics
$2.35 /

+0.055 (+2.40%)

TMO Thermo Fisher
$560.75 /

-2.085 (-0.37%)

TCRR TCR2 Therapeutics
$15.71 /

-0.51 (-3.14%)

TAK Takeda Pharmaceutical
$17.21 /

+0.205 (+1.21%)

SYNH Syneos Health
$93.78 /

+0.07 (+0.07%)

RHHBY Roche
$46.82 /

-0.04 (-0.09%)

REGN Regeneron
$652.73 /

+2.13 (+0.33%)

PFE Pfizer
$44.46 /

-0.31 (-0.69%)

ORIC Oric Pharmaceuticals
$24.49 /

-0.31 (-1.25%)

NVS Novartis
$84.37 /

-0.695 (-0.82%)

LPTX Leap Therapeutics
$2.52 /

+0.57 (+29.23%)

LLY Eli Lilly
$230.95 /

-2.72 (-1.16%)

IPSEY Ipsen
$24.32 /

+0.23 (+0.95%)

IDYA Ideaya Biosciences
$25.90 /

-0.1 (-0.38%)

GSK GlaxoSmithKline
$39.10 /

-0.11 (-0.28%)

GMAB Genmab
$42.26 /

-0.575 (-1.34%)

GILD Gilead
$71.32 /

-0.45 (-0.63%)

GH Guardant Health
$127.00 /

-0.01 (-0.01%)

EXAS Exact Sciences
$102.81 /

-1.83 (-1.75%)

DCPH Deciphera
$31.77 /

+0.72 (+2.32%)

CALA Calithera Biosciences
$2.05 /

-0.04 (-1.91%)

BYSI BeyondSpring
$22.50 /

-0.48 (-2.09%)

BMY Bristol-Myers
$61.22 /

-0.78 (-1.26%)

BGNE BeiGene
$385.26 /

+10.94 (+2.92%)

AYLA Ayala Pharmaceuticals
$12.26 /

-1.76 (-12.55%)

ABBV AbbVie
$108.08 /

+0.29 (+0.27%)

ABBV AbbVie
$108.08 /

+0.29 (+0.27%)

09/14/21 Barclays
Regenxbio price target raised to $82 from $79 at Barclays
09/13/21 Chardan
Regenxbio pact with AbbVie accelerates RGX-314 'value capture,' says Chardan
09/08/21 JPMorgan
AbbVie offers 'best risk/reward story in the group,' says JPMorgan
09/07/21 Morgan Stanley
Morgan Stanley cuts Vertex Pharmaceuticals to Underweight amid AbbVie overhang
AYLA Ayala Pharmaceuticals
$12.26 /

-1.76 (-12.55%)

07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with Buy, $29 target at Ladenburg
07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with a Buy at Ladenburg
12/07/20
Fly Intel: Top five analyst initiations
12/07/20 Roth Capital
Ayala Pharmaceuticals initiated with a Buy at Roth Capital
DCPH Deciphera
$31.77 /

+0.72 (+2.32%)

08/04/21 H.C. Wainwright
Deciphera price target lowered to $70 from $75 at H.C. Wainwright
05/05/21 Barclays
Deciphera price target lowered to $65 from $70 at Barclays
05/05/21 H.C. Wainwright
Deciphera price target lowered to $75 from $80 at H.C. Wainwright
05/05/21 Piper Sandler
Deciphera price target lowered to $60 from $75 at Piper Sandler
GMAB Genmab
$42.26 /

-0.575 (-1.34%)

09/16/21
Fly Intel: Top five analyst downgrades
09/16/21 Jefferies
Genmab downgraded to Hold from Buy at Jefferies
09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley cuts Genmab to Underweight amid high investor expectations
LPTX Leap Therapeutics
$2.52 /

+0.57 (+29.23%)

09/16/21 Piper Sandler
Leap data show 'very favorable early signal,' says Piper Sandler
09/13/21 Raymond James
Leap Therapeutics price target raised to $4 from $3 at Raymond James
09/13/21 Piper Sandler
Leap combo sees 'strong' early response rate, says Piper Sandler
06/03/21 Baird
Leap Therapeutics transferred with Outperform at Baird
ORIC Oric Pharmaceuticals
$24.49 /

-0.31 (-1.25%)

07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy after tumor data at Citi
07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy from Neutral at Citi
03/25/21 H.C. Wainwright
Oric Pharmaceuticals price target raised to $54 from $52 at H.C. Wainwright
01/25/21 Citi
Oric Pharmaceuticals downgraded to Neutral from Buy at Citi
SYNH Syneos Health
$93.78 /

+0.07 (+0.07%)

08/04/21 Credit Suisse
Syneos Health assumed with an Outperform at Credit Suisse
07/13/21 Barclays
Syneos Health price target raised to $102 from $90 at Barclays
06/02/21 Truist
Syneos Health price target raised to $104 from $88 at Truist
04/30/21 Mizuho
Syneos Health price target raised to $90 from $82 at Mizuho
BGNE BeiGene
$385.26 /

+10.94 (+2.92%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
BMY Bristol-Myers
$61.22 /

-0.78 (-1.26%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
BYSI BeyondSpring
$22.50 /

-0.48 (-2.09%)

09/08/21 Baird
BeyondSpring initiated with an Outperform at Baird
08/04/21 Evercore ISI
BeyondSpring price target raised to $95 from $30 at Evercore ISI
08/04/21 William Blair
BeyondSpring may have new standard of care in lung cancer, says William Blair
08/04/21 H.C. Wainwright
Wainwright upgrades BeyondSpring with $100 target on lung cancer data
CALA Calithera Biosciences
$2.05 /

-0.04 (-1.91%)

01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform at SVB Leerink
01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform from Outperform at SVB Leerink
01/05/21 Citi
Calithera Biosciences price target lowered to $5 from $10 at Citi
01/05/21 H.C. Wainwright
Calithera Biosciences price target lowered to $4 from $9.50 at H.C. Wainwright
GILD Gilead
$71.32 /

-0.45 (-0.63%)

07/30/21 BMO Capital
Gilead price target raised to $72 from $67 at BMO Capital
07/30/21 RBC Capital
Gilead price target raised to $84 from $81 at RBC Capital
06/29/21 Jefferies
Gilead data should move Yescarta up to second line in DLBCL, says Jefferies
GH Guardant Health
$127.00 /

-0.01 (-0.01%)

08/09/21 Canaccord
Guardant Health price target lowered to $180 from $195 at Canaccord
06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Guardant Health initiated with a Market Perform at Raymond James
LLY Eli Lilly
$230.95 /

-2.72 (-1.16%)

09/02/21 SVB Leerink
AbbVie price target lowered to $142 from $148 at SVB Leerink
08/30/21 Cowen
Eli Lilly price target raised to $300 from $250 at Cowen
08/30/21 Citi
Lexicon price target raised to $20 from $13 at Citi
IPSEY Ipsen
$24.32 /

+0.23 (+0.95%)

08/16/21 Morgan Stanley
Ipsen price target lowered to EUR 88 from EUR 92 at Morgan Stanley
08/03/21 Morgan Stanley
Ipsen price target raised to EUR 92 from EUR 85 at Morgan Stanley
08/02/21 Societe Generale
Ipsen price target raised to EUR 101 from EUR 90 at Societe Generale
07/30/21 Credit Suisse
Ipsen price target raised to EUR 90 from EUR 75 at Credit Suisse
EXAS Exact Sciences
$102.81 /

-1.83 (-1.75%)

09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
09/15/21 Canaccord
Exact Sciences progress in MRD space a positive, says Canaccord
09/01/21 Baird
UnitedHealth update to CRC screening coverage not a surprise, says Baird
IDYA Ideaya Biosciences
$25.90 /

-0.1 (-0.38%)

06/03/21 Baird
Ideaya Biosciences assumed with an Outperform at Baird
04/22/21 Roth Capital
Ideaya Biosciences price target raised to $38 from $31 at Roth Capital
04/19/21 H.C. Wainwright
Ideaya Biosciences price target raised to $35 from $29 at H.C. Wainwright
04/16/21 Roth Capital
Ideaya Biosciences price target raised to $31 from $23 at Roth Capital
GSK GlaxoSmithKline
$39.10 /

-0.11 (-0.28%)

08/26/21 UBS
GlaxoSmithKline price target raised to 1,540 GBp from 1,485 GBp at UBS
08/20/21 JPMorgan
GlaxoSmithKline price target raised to 1,500 GBp from 1,300 GBp at JPMorgan
08/19/21 Berenberg
GlaxoSmithKline price target raised to 1,625 GBp from 1,570 GBp at Berenberg
RHHBY Roche
$46.82 /

-0.04 (-0.09%)

09/07/21 UBS
Roche price target raised to CHF 350 from CHF 345 at UBS
08/02/21 JPMorgan
Roche price target raised to CHF 360 from CHF 310 at JPMorgan
07/27/21 Societe Generale
Roche price target raised to CHF 353 from CHF 340 at Societe Generale
REGN Regeneron
$652.73 /

+2.13 (+0.33%)

09/15/21 Cantor Fitzgerald
Regeneron price target raised to $700 from $670 at Cantor Fitzgerald
09/15/21 H.C. Wainwright
Regeneron price target raised to $831 from $787 at H.C. Wainwright
09/15/21 Piper Sandler
Regeneron price target raised to $690 from $675 at Piper Sandler
09/09/21
Fly Intel: Top five analyst initiations
PFE Pfizer
$44.46 /

-0.31 (-0.69%)

09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
09/13/21 JPMorgan
Pfizer price target raised to $42 from $40 at JPMorgan
TAK Takeda Pharmaceutical
$17.21 /

+0.205 (+1.21%)

08/03/21 Piper Sandler
Arcturus strength attributable to large pharma's interest in mRNA, says Piper
04/27/21 Chardan
LogicBio collaborations may signal recognition of platforms, says Chardan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
TMO Thermo Fisher
$560.75 /

-2.085 (-0.37%)

08/04/21 Credit Suisse
Thermo Fisher assumed with an Outperform at Credit Suisse
08/04/21 Argus
Thermo Fisher price target raised to $600 from $530 at Argus
07/29/21 Cowen
Thermo Fisher price target raised to $560 from $525 at Cowen
07/29/21 BTIG
Thermo Fisher price target raised to $610 from $590 at BTIG
TCRR TCR2 Therapeutics
$15.71 /

-0.51 (-3.14%)

08/06/21 BMO Capital
TCR2 Therapeutics price target lowered to $44 from $53 at BMO Capital
06/24/21 Goldman Sachs
TCR2 Therapeutics initiated with a Buy at Goldman Sachs
06/11/21 BMO Capital
TCR2 Therapeutics coverage transferred at BMO Capital
05/14/21 Wedbush
TCR2 Therapeutics price target lowered to $45 from $57 at Wedbush
VERU Veru
$8.76 /

-0.04 (-0.45%)

04/13/21 Jefferies
Veru initiated with a Buy at Jefferies
02/11/21 Oppenheimer
Veru price target raised to $24 from $19 at Oppenheimer
02/11/21 H.C. Wainwright
Veru price target raised to $22 from $17 at H.C. Wainwright
02/09/21 H.C. Wainwright
Veru price target raised to $17 from $12 at H.C. Wainwright
VBLT VBL Therapeutics
$2.35 /

+0.055 (+2.40%)

08/30/21 Roth Capital
Roth bullish on VBL Therapeutics as U.S. Phase 3 OVAL trial enrollment resumes
06/15/21 Roth Capital
Roth does not see material change to VBL readout timelines
06/03/21 Roth Capital
Roth Capital ups VBL Therapeutics target to $7 on OVAL primary endpoint update
05/18/21 Guggenheim
VBL Therapeutics initiated with a Buy at Guggenheim
VTRS Viatris
$13.70 /

-0.03 (-0.22%)

06/15/21 Citi
Viatris initiated with a Neutral at Citi
04/06/21 RBC Capital
Viatris transferred with an Outperform at RBC Capital
03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
03/12/21 Piper Sandler
Viatris price target lowered to $16 from $17 at Piper Sandler
NVS Novartis
$84.37 /

-0.695 (-0.82%)

09/07/21 Wedbush
Wedbush downgrades Xoma to Neutral, cuts target to $22
07/28/21 JPMorgan
Novartis price target raised to CHF 84 from CHF 80 at JPMorgan
07/27/21 Jefferies
Point Biopharma initiated with a Hold at Jefferies
VTRS Viatris
$13.70 /

-0.03 (-0.22%)

VERU Veru
$8.76 /

-0.04 (-0.45%)

VBLT VBL Therapeutics
$2.35 /

+0.055 (+2.40%)

TMO Thermo Fisher
$560.75 /

-2.085 (-0.37%)

TCRR TCR2 Therapeutics
$15.71 /

-0.51 (-3.14%)

TAK Takeda Pharmaceutical
$17.21 /

+0.205 (+1.21%)

SYNH Syneos Health
$93.78 /

+0.07 (+0.07%)

RHHBY Roche
$46.82 /

-0.04 (-0.09%)

REGN Regeneron
$652.73 /

+2.13 (+0.33%)

PFE Pfizer
$44.46 /

-0.31 (-0.69%)

ORIC Oric Pharmaceuticals
$24.49 /

-0.31 (-1.25%)

NVS Novartis
$84.37 /

-0.695 (-0.82%)

LPTX Leap Therapeutics
$2.52 /

+0.57 (+29.23%)

LLY Eli Lilly
$230.95 /

-2.72 (-1.16%)

IDYA Ideaya Biosciences
$25.90 /

-0.1 (-0.38%)

GSK GlaxoSmithKline
$39.10 /

-0.11 (-0.28%)

GILD Gilead
$71.32 /

-0.45 (-0.63%)

GH Guardant Health
$127.00 /

-0.01 (-0.01%)

EXAS Exact Sciences
$102.81 /

-1.83 (-1.75%)

DCPH Deciphera
$31.77 /

+0.72 (+2.32%)

CALA Calithera Biosciences
$2.05 /

-0.04 (-1.91%)

BYSI BeyondSpring
$22.50 /

-0.48 (-2.09%)

BMY Bristol-Myers
$61.22 /

-0.78 (-1.26%)

BGNE BeiGene
$385.26 /

+10.94 (+2.92%)

AYLA Ayala Pharmaceuticals
$12.26 /

-1.76 (-12.55%)

ABBV AbbVie
$108.08 /

+0.29 (+0.27%)

  • 08
    Jul
  • 03
    Jun
  • 04
    May
  • 09
    Apr
  • 01
    Mar
  • 18
    Feb
  • 20
    Jan
  • 02
    Dec
  • 02
    Dec
  • 19
    Nov
  • 13
    Nov
  • 07
    Oct
TMO Thermo Fisher
$560.75 /

-2.085 (-0.37%)

TAK Takeda Pharmaceutical
$17.21 /

+0.205 (+1.21%)

SYNH Syneos Health
$93.78 /

+0.07 (+0.07%)

RHHBY Roche
$46.82 /

-0.04 (-0.09%)

REGN Regeneron
$652.73 /

+2.13 (+0.33%)

PFE Pfizer
$44.46 /

-0.31 (-0.69%)

NVS Novartis
$84.37 /

-0.695 (-0.82%)

LLY Eli Lilly
$230.95 /

-2.72 (-1.16%)

GSK GlaxoSmithKline
$39.10 /

-0.11 (-0.28%)

GILD Gilead
$71.32 /

-0.45 (-0.63%)

EXAS Exact Sciences
$102.81 /

-1.83 (-1.75%)

BMY Bristol-Myers
$61.22 /

-0.78 (-1.26%)

BGNE BeiGene
$385.26 /

+10.94 (+2.92%)

ABBV AbbVie
$108.08 /

+0.29 (+0.27%)

VERU Veru
$8.76 /

-0.04 (-0.45%)

TMO Thermo Fisher
$560.75 /

-2.085 (-0.37%)

TAK Takeda Pharmaceutical
$17.21 /

+0.205 (+1.21%)

RHHBY Roche
$46.82 /

-0.04 (-0.09%)

REGN Regeneron
$652.73 /

+2.13 (+0.33%)

PFE Pfizer
$44.46 /

-0.31 (-0.69%)

ORIC Oric Pharmaceuticals
$24.49 /

-0.31 (-1.25%)

NVS Novartis
$84.37 /

-0.695 (-0.82%)

LPTX Leap Therapeutics
$2.52 /

+0.57 (+29.23%)

LLY Eli Lilly
$230.95 /

-2.72 (-1.16%)

IDYA Ideaya Biosciences
$25.90 /

-0.1 (-0.38%)

GSK GlaxoSmithKline
$39.10 /

-0.11 (-0.28%)

GMAB Genmab
$42.26 /

-0.575 (-1.34%)

GILD Gilead
$71.32 /

-0.45 (-0.63%)

GH Guardant Health
$127.00 /

-0.01 (-0.01%)

EXAS Exact Sciences
$102.81 /

-1.83 (-1.75%)

BYSI BeyondSpring
$22.50 /

-0.48 (-2.09%)

BMY Bristol-Myers
$61.22 /

-0.78 (-1.26%)

ABBV AbbVie
$108.08 /

+0.29 (+0.27%)

VTRS Viatris
$13.70 /

-0.03 (-0.22%)

VERU Veru
$8.76 /

-0.04 (-0.45%)

TAK Takeda Pharmaceutical
$17.21 /

+0.205 (+1.21%)

REGN Regeneron
$652.73 /

+2.13 (+0.33%)

PFE Pfizer
$44.46 /

-0.31 (-0.69%)

LLY Eli Lilly
$230.95 /

-2.72 (-1.16%)

GSK GlaxoSmithKline
$39.10 /

-0.11 (-0.28%)

GILD Gilead
$71.32 /

-0.45 (-0.63%)

BYSI BeyondSpring
$22.50 /

-0.48 (-2.09%)

BMY Bristol-Myers
$61.22 /

-0.78 (-1.26%)

ABBV AbbVie
$108.08 /

+0.29 (+0.27%)

Thursday
Hot Stocks
Eli Lilly says FDA expands EUA for bamlanivimab-etesevimab combo » 15:58
09/16/21
09/16
15:58
09/16/21
15:58
LLY

Eli Lilly

$231.47 /

-2.2 (-0.94%)

The U.S. Food and Drug…

The U.S. Food and Drug Administration has expanded the Emergency Use Authorization for bamlanivimab 700 mg and etesevimab 1400 mg administered together to include post-exposure prophylaxis in certain individuals for the prevention of SARS-CoV-2 infection, Eli Lilly and Company announced. The neutralizing antibodies can now be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison. This authorization follows the national reopening of distribution earlier this month. The expanded authorization is based on data from BLAZE-2, a study conducted in partnership with the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, and the COVID-19 Prevention Network, that enrolled residents and staff at long-term care facilities, commonly referred to as nursing homes, across the U.S. In this placebo-controlled Phase 3 study, bamlanivimab 4200 mg reduced the risk of contracting symptomatic COVID-19 by up to 80 percent in nursing home residents and up to 57 percent among residents and staff of long-term care facilities.

ShowHide Related Items >><<
LLY Eli Lilly
$231.47 /

-2.2 (-0.94%)

LLY Eli Lilly
$231.47 /

-2.2 (-0.94%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/02/21 SVB Leerink
AbbVie price target lowered to $142 from $148 at SVB Leerink
08/30/21 Cowen
Eli Lilly price target raised to $300 from $250 at Cowen
08/30/21 Citi
Lexicon price target raised to $20 from $13 at Citi
LLY Eli Lilly
$231.47 /

-2.2 (-0.94%)

LLY Eli Lilly
$231.47 /

-2.2 (-0.94%)

LLY Eli Lilly
$231.47 /

-2.2 (-0.94%)

LLY Eli Lilly
$231.47 /

-2.2 (-0.94%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.